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Abstract
A large outbreak of Shiga toxin (Stx)-producing enteroaggregative Escherichia coli (EAEC) O104:H4 occurred in northern
Germany. From this outbreak, at least 900 patients developed hemolytic uremic syndrome (HUS), resulting in more than 50
deaths. Thirty percent of the HUS patients showed encephalopathy. We previously established a mouse model with
encephalopathy associated with blood brain barrier (BBB) damage after oral infection with the Shiga toxin (Stx) 2c-
producing Escherichia coli O157: H- strain E32511 (E32511). In this model, we detected high expression of the Stx receptor
synthase enzyme, glycosphingolipid globotriaosylceramide (Gb3) synthase, in endothelial cells (ECs) and neurons in the
reticular formation of the medulla oblongata by in situ hybridization. Caspase-3 was activated in neurons in the reticular
formation of the medulla oblongata and the anterior horn of the spinal cord. Astrocytes (ASTs) were activated in the
medulla oblongata and spinal cord, and a decrease in aquaporin 4 around the ECs suggested that BBB integrity was
compromised directly by Stx2c or through the activation of ASTs. We also report the effectiveness of azithromycin (AZM) in
our model. Moreover, AZM strongly inhibited the release of Stx2c from E32511 in vitro.
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Introduction
A large outbreak of Shiga toxin (Stx)-producing enteroaggrega-
tive Escherichia coli (EAEC) O104:H4 occurred in northern
Germany in May 2011, resulting in at least 4,000 infections
reported in 16 countries across Europe and North America [1,2].
Of these cases, more than 900 developed hemolytic uremic
syndrome (HUS), resulting in more than 54 deaths. In the German
outbreak, 30% of HUS patients showed signs and symptoms of
encephalopathy, including delirium, stimulus-sensitive myoclonus,
aphasia, and epileptic seizures requiring mechanical ventilation
[3]. These patients were treated with IgG, and IgG complexes
were depleted by immunoadsorption [3]. This treatment was
effective in improving the severe neurological complications. In
Japan, between late April and early May 2011, an outbreak of
enterohemorrhagic E. coli (EHEC) O111 infection occurred
mainly in the Toyama, Fukui prefecture and Yokohama City. A
total of 169 people suffered from diarrhea, 30 (17.8%) developed
HUS, and surprisingly, encephalopathy developed in 14 (47%) of
the HUS patients. Furthermore, 5 hospitalized patients died with
neurological manifestations, including somnolence, coma, and
convulsions [4].
Central nervous system (CNS) dysfunction is an important
predictive factor for HUS and mortality in children [5–7]. In
1994, we established a mouse model of CNS disorders by oral
infection with the Stx2c-producing EHEC O157: H- strain
E32511/HSC (E32511), resulting in damage to the endothelial
cells (ECs) of capillaries and to nerve fibers in the cerebral cortex
and spinal cord in the mice [8]. In this model, we succeeded in
detecting Stx2c in the nerve fibers of the spinal cord by
immunohistochemical electron microscopic examination. In an-
other model, Stx2-induced brain edema detected by magnetic
resonance imaging (MRI) in rabbits was considered a manifesta-
tion of the deterioration of the blood-brain barrier (BBB); Stx2
immunoreactivity was detected on the apical plasma membrane of
the endothelial cells in the hypothalamic lesion [9]. Steinborn et al.
also reported that 100% of six patients with post-diarrhea HUS
accompanied by serious CNS involvement had basal ganglia
lesions detected by MRI [10]. In the Stx2-treated rabbit model of
acute encephalopathy, MRI showed high intensity areas in the
spinal cord and medulla oblongata. Based on the analysis of the
relation between mean arterial pressure and renal sympathetic
nerve activity, the cause of death in the rabbit model was
circulatory failure caused by impairment of the cardiovascular
center in the medulla [11].
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EHEC has two major types of toxins, Stx1 and Stx2, which are
comprised of 1A and 5B protein subunits [12]. The A subunit has
N-glycosidase activity that removes adenine 4324 of 28S RNA of
the 60S ribosomal subunit [13]. The amino acid sequence identity
between the A subunits of Stx1 and Stx2 has been reported to be
only 55% [14]. On the other hand, Stx produced by Shigella
dysenteriae is identical to Stx1 [15]. Stx2 had an LD50 approxi-
mately 400 times lower than that of Stx1 when injected
intravenously (i.v.) or intraperitoneally (i.p.) into mice [16]. In a
baboon model, i.v. administration of Stx2 (25 ng/kg, 12 h each, 4
times) caused HUS, while administration of the same amount of
Stx1 did not [17]. Each B subunit binds with high affinity to the
glycosphingolipid globotriaosylceramide (Gb3), which is present in
some eukaryotic cells [18]. It has been demonstrated that Gb3
(CD77) is up-regulated by lipopolysaccharide (LPS), TNF-a, and
IL-1b [19,20]. CD77 is a marker of human germinal centre B cells
[21]. The life-threatening CNS manifestations mediated by Stxs
are associated with cell death of human brain microvascular
endothelial cells (HBMEC). However, the type of Stx that induces
cell death related to loss of 28S RNA is still unclear. Bauwens et al.
reported that Stx2 caused apoptosis in HBMECs and EA.Hy923
human macrovascular ECs, but Stx1 only caused necrosis in
EA.Hy923 macrovascular ECs [22]. We previously reported that
induction of apoptosis by Stx1 in HeLa cells requires caspase-6, -8,
and -9 within 4 h, followed by activation of caspase-3, which leads
to fragmentation of nuclear DNA [23]. We also reported that Stx2
treatment induced a marked up-regulation of C/EBP homologue
protein/growth arrest (CHOP) genes, resulting in endoplasmic
reticulum stress (ER stress) [24]. In this study, we performed in situ
hybridization (ISH) using a Gb3 synthase probe in mouse brain.
Previously, we reported that a disruption of BBB integrity was
detected in the E32511 model (see Materials and Methods) [8].
However, the mechanism of the disruption of the BBB is not clear;
because Gb3 was not detected in ECs of control mice [25]. Recent
reports showed that Stx1- and LPS-induced astrocyte (AST)
responses could influence the integrity of brain ECs and BBB
dysfunction in vitro [26]. It is not yet known whether microgliosis is
associated with the pathogenesis of the brain impairment. The
water channel aquaporin 4 (AQP4) is located in the perivascular
end-feet of astrocytes (ASTs) in the brain. An increase in glial
fibrillary acidic protein (GFAP) reactivity in perivascular ASTs
caused a down-regulation of AQP4 in rats injected with
supernatant from a culture of recombinant E. coli expressing
Stx2 [27].
No treatment has been established for EHEC-related HUS and
encephalopathy. In 1996, a large outbreak of EHEC O157:H7
infection occurred among schoolchildren in Sakai City, Osaka,
Japan. As many as 10,000 patients suffered from diarrhea and
hemorrhagic colitis, 150 patients developed HUS, and 3 children
died. After the outbreak in Japan, the treatment guidelines for
EHEC infection written by the Ministry of Public Welfare
recommended administration of antimicrobial agents, especially
fosfomycin (FOM), kanamycin (KM), and norfloxacin (NFLX). As
the rationale for this opinion, it was suggested that the
administration of chemotherapy at the earliest point of the EHEC
infection removes the bacteria and lowers the level of Stxs in the
colon. Also, from surveys of physicians who treated EHEC
patients, FOM was the most frequently administered, and the
authors emphasized that administration within the first two days of
illness reduced the risk of HUS [28]. We previously reported an
evaluation of the therapeutic effects of the antimicrobial agents
FOM, minocycline (MINO), KM and NFLX in our EHEC
E32511-infected mouse model [8]. The mortality rate of mice
treated with MINO, KM and NFLX was significantly lower than
that of the control group, but FOM was not effective [29].
Recently, we discovered an effective therapy in the Stx2 toxemic
rabbit. A steroid pulse therapy of betamethasone sodium
phosphate (BSP) injected twice a day for 2 days statistically
reduced the mortality rate and improved the survival period of
Stx2 toxemic rabbits [30]. In a study by Ohara et al, immature
mice was the animal model used [31]. Results from Ohara et al`s
study showed that azithromycin (AZM) administered i.p. at higher
concentrations (10 mg/kg) and three times (24, 48, and 78 h) after
STEC inoculation prevented the death of these mice compared
with ciprofloxacin (CPFX) treatment group. Moreover, they
reported that AZM was effective to reduce the production of the
cytokine level such as TNF-a, IL-1b, and IL-6 in Stx-treated
monocytes and in serum of Stx-injected mice. In our study, we
confirmed the effectiveness of AZM in our E32511 model that
showed neurological manifestations and fatal acute encephalopa-
thy after oral infection with 1011 CFU/mouse of E32511 and
simultaneous i.p. injection with mitomycin C (MMC).
In the current study, apoptosis accompanied by caspase-3
activation was detected in the motor neurons in the anterior horn
of the spinal cord and in neurons in the reticular formation of the
medulla oblongata. Additionally, GFAP-immunopositive reactive
ASTs were observed around the blood vessels and neurons in the
E32511 model. Gb3 synthase mRNA was up-regulated in those
lesions as a response to the oral inoculation of E32511 or an i.p.
injection of LPS. Our mouse model may recapitulate the CNS
pathology of E32511 strain, represented by the expression of Gb3,
apoptosis in neurons, and disruption of the BBB associated with
reactive ASTs.
Materials and Methods
Ethics statement
Animal experiments were carried out in strict accordance with
the recommendations in Guidelines for Proper Conduct of Animal
Experiments of the Science Council of Japan. The protocol was
approved by the Ethics Committee on Animal Experiments of
Kyushu University, Japan (Permit Number: A23-141-1). All
surgical procedures were performed under sevoflurane anesthesia,
and all efforts were made to minimize suffering.
Bacterial strains
E32511 was used in this study [8]. Streptomycin (SM)- and
Mitomycin C (MMC)-resistant E32511 were grown in nutrient
agar supplemented with 100 mg/mL of SM (Wako Pure Chemical
Industries, Ltd., Osaka, Japan), 0.5 mg/mL of MMC (Kyowa
Hakko Kogyo Co. Ltd., Tokyo, Japan). E. coli K-12, which is
resistant to SM and MMC, was used as a negative control.
E32511/HSC and E. coli K-12 were grown with shaking for 17 h
in Luria-Bertani broth (LB broth) at 37uC. The bacterial pellets
were then harvested by centrifugation at 60006g for 25 min at
4uC, before being washed twice with phosphate-buffer saline (PBS)
by centrifugation (60006g for 20 min at 4uC). Finally, bacterial
pellets were suspended in PBS and the appropriate number of
CFUs was given orally to the mice.
Shiga toxin 2 (Stx2)
Purified Stx2 was used and was determined to be free of
detectable LPS by the Toxicolor test (Seikagaku Kogyo Co.,
Tokyo, Japan), sodium dodecyl sufate-polyacrylamide gel electro-
phoresis, and silver staining.
Encephalopathy Caused by Stx2c Producing E. coli
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Animals
Four week old female ICR outbred mice purchased from Japan
SLC, Inc. (Shizuoka, Japan) were used for all in vivo experiments in
this study. They were housed in cages with a 12 h light-dark cycle
and free access to laboratory food and distilled water.
Mouse infection model of acute encephalopathy
For the in vivo experiments, the mice were divided into groups of
5 or 6. In this study, the mice were given E32511/HSC orally and
MMC i.p. [8]. Briefly, all mice were given SM-containing drinking
water (5 g/L) ad libitum to reduce the level of their normal
intestinal flora [32]. On day 3 of SM treatment, all the mice were
completely deprived of food for 12 h until bacterial inoculation.
Each mouse was infected with 0.5 mL of bacterial suspension
using a sterile disposable feeding needle (diameter, 1.9 mm;
length, 38 mm, Fuchigami Co. Ltd. Nara, Japan) attached to a
syringe passed into the stomach by orogastric inoculation.
Simultaneously, they were injected i.p. with 2.5 mg/g MMC. We
reported that 90% of the mice infected with 561010 CFU of
E32511 orally plus i.p. injection of MMC developed weight loss,
flaccid paralysis and tremor, culminating in death [8]. In this
study, the bacterial suspension of E32511 was adjusted to
161011 CFU in PBS and caused 100% death. After the
completion of treatment, they were housed according to the
treatment groups and given food and SM-containing drinking
water (5 g/L) ad libitum. The mice were observed twice daily for 2
weeks, for the survival or death of mice and for signs of illness, and
measurement of body weight (BW).
Preparation of mouse brain and spinal cord tissues
The mouse brain and spinal cord tissue were harvested
immediately after the mice were anesthetized. Thereafter, mice
were perfused with 10 mL of 16 PBS solution through the left
cardiac ventricle followed by 10 mL of 4% paraformaldehyde
(PFA) (Wako Laboratory Chemicals, Osaka, Japan)/PBS to fix the
organ tissue. Brain and spinal cord were harvested and fixed in 4%
PFA/PBS. Then, the brain and spinal cord were processed for
immunohistochemical examination.
In situ hybridization (ISH) of Gb3-synthase in mouse brain
For detection of Alpha 1,4-galactosyltransferase (Gb3 synthase;
Accession # NM_001170954) mRNA, a 532-bp DNA fragment
corresponding to nucleotide positions 155-686 of mouse Gb3
synthase was sub-cloned into pGEMT-Easy vector (Promega,
Madison, WI, USA) and used to generate sense or antisense RNA
probes. We hybridized paraffin-embedded spinal cord sections
(6 mm) with digoxigenin-labeled RNA probes at 60uC for 16 h.
The bound label was detected using NBT-BCIP (Sigma-Aldrich),
an alkaline phosphate color substrate. Sections were counter-
stained with Kernechtrot stain solution (Muto Pure Chemicals
Co., Ltd. Tokyo, Japan). Stained slides were examined using a
Keyence (Osaka, Japan) HS All-in-one Fluorescence Microscope
BZ-9000E.
Immunohistochemistry
Formalin-fixed, paraffin-embedded tissue blocks were cut into
3 mm thick sections. The sections (except for those to be stained for
GFAP, AQP4, and Iba-1) were deparaffinized in xylene,
dehydrated in an ethanol gradient and pretreated for heat-based
antigen retrieval with 10 nmol/L citrate buffer solution (pH 6.0)
for 20 min in an autoclave. The sections were incubated with 5%
nonfat milk to eliminate nonspecific binding of the antibody (Ab),
and were then incubated overnight at 4uC with the polyclonal
anti-cleaved caspase-3 Ab (1:400, Cell Signaling Technology, Inc,
Beverly, MA, USA) diluted with PBS containing 5% BSA and
0.1% Tween 20. After endogenous peroxidase activity was blocked
with methanol containing 1% H2O2, the sections were incubated
with an HRP-labeled anti-rabbit secondary antibody, HistoFine
(Dako, Glostrup, Denmark) for 30 min. The target proteins were
visualized with the peroxidase stain DAB kit (Nacalai Tesque,
Kyoto, Japan). Nuclei were counterstained with hematoxylin. For
the immunostaining of astrocytes and AQP4, polyclonal rabbit
anti-GFAP (1:1000; Dako Cytomation, Glostrup, Denmark) and
polyclonal rabbit anti-AQP4 (1:500; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) Abs were used [33]. For the immuno-
staining of microglial activation, a rabbit polyclonal antibody anti-
Iba1 Ab (1:500; Wako Pure Chemical Industries Ltd.) was used
and diluted in PBS containing 5% BSA and 0.1% Tween 20 (final
concentration 1 mg/mL). Specimens were examined using a
Keyence HS All-in-one Fluorescence Microscope BZ-9000E.
Three-dimensional (3D) images
Serial images of mice spinal cord were captured with a Keyence
HS All-in-one Fluorescence Microscope BZ-9000E at 206
magnification. Thereafter, using the serial images, the 3D
reconstruction was generated using Neurolucida software (Micro
Bright Field Japan, Inc., Chiba, Japan).
Preparation of AZM, other antimicrobial agents and MIC
against strain E32511
AZM was obtained from Pfizer, NY, USA; FOM and KM was
purchased from Meiji Seika Kaisha, Ltd., Tokyo, Japan. NFLX,
OFLX and CPFX were purchased from Sigma-Aldrich Co.,
Tokyo, Japan. FOM was diluted with distilled water, and AZM
was prepared as a stock solution and dissolved with 50 mM citrate
buffer, pH 5.3. NFLX and OFLX were diluted with 0.1 N NaOH
at 1 mg/mL as a stock solution and diluted with distilled water.
CPFX was diluted with 0.1 N HCl at 1 mg/mL as a stock solution
and diluted with distilled water.
The Minimal Inhibitory Concentration (MIC) of each antibiotic
against E32511/HSC were determined using a Broth Dilution
Method according to the recommendations of the National
Committee for Clinical Laboratory Standards (NCCLS 1993)
except for FOM, the MIC of which was determined using the agar
dilution method [34]. The range of antimicrobial agent concen-
trations for E32511/HSC were : AZM 512–0.125 mg/mL; FOM
12.48–0.195 mg/mL; KM 100–1.5625 mg/mL; NFLX 0.784–
0.0245 mg/mL; OFLX 1.6–0.00625 mg/mL; and, CPFX 0.96–
0.00375 mg/mL. The bacterial cultures containing 2-fold serially
diluted antibiotics were incubated in a 37uC shaker with aeration
for 18 h. The MIC of each antibiotic was obtained by determining
the highest dilution or lowest dose of each antibiotic that inhibited
the growth of bacteria.
Bacterial count and concentration of Stx2c
The effect of AZM and other antimicrobial agents in vitro was
assayed at sub-minimum inhibitory concentrations. Samples were
obtained from the MIC examination. Briefly, after 18 h incuba-
tion, the bacterial cultures with 0.56MIC of each antibiotic 2-fold
serially diluted were plated on Luria Bertani (LB) agar plates and
the bacterial colonies counted, after which the bacterial cultures
were collected and centrifuged at 95006g, 4uC for 15 minutes.
Culture supernatant was collected and filtered through a 0.22 mM
filter before determining the Stx2c level in the culture supernatant
using a Reverse Passive Latex Agglutination (RPLA) test kit
(Denka Seiken Co.).
Encephalopathy Caused by Stx2c Producing E. coli
PLOS ONE | www.plosone.org 3 March 2013 | Volume 8 | Issue 3 | e58959
Statistical Analysis
Data were analyzed with SPSS Statistics 19.0 (IBM Japan,
Tokyo, Japan). The significance of the survival rate from each
treatment group was compared using Kaplan-Meier test followed
by a pair-wise comparison of Log Rank (Mantel-Cox) test.
Student’s t-test was used to show the significant values between
negative control, positive control and treatment groups. Spear-
man’s test was used to show the correlation between the dose of
AZM and the increase in BW of E32511-infected mice.
Significance was set at a value of p,0.05 in all cases.
Results
Localization of Gb3 synthase mRNA by ISH in the E32511
model and LPS-injected mouse
Three candidate probes for ISH are shown in (Table S1). To
select the best probe for ISH, we did preliminary tests on mouse
brain and we selected Gb3 synthase-1 (155–186) as the best probe.
In our E32511 strain model, the anti-sense probes showed that
Gb3 synthase mRNA was up-regulated in the reticular formation
of the medulla oblongata (Figure1A; Anti-sense). In the same
region, Gb3 synthase mRNA was detected in ECs (Figure1, A1
and A2; Anti-sense Endothelial cells) and neurons (Figure1, A1
and A2; Anti-sense Neurons). As a positive control, LPS (500 mg/
kg) was administered i.p. to the mice once a day for 3 consecutive
days. The mouse brain was harvested on day 4 after three days of
LPS administration. In the LPS-injected mouse model, we also
detected Gb3 synthase mRNA in the reticular formation of the
medulla oblongata using the anti-sense probes (Figure1B; Anti-
sense). Additionally, Gb3 synthase mRNA was up-regulated in the
spinal cord (Figure1C). In the spinal cord, Gb3 synthase mRNA
expression was detected in ECs (Figure1, C.1; Anti-sense
Endothelial cells) and motor neurons in the anterior horn (Figure1,
C.1; Anti-sense Neurons). In the control mice, Gb3 synthase
mRNA was not detected (Figure S1A). b-actin mRNA, as a
positive control, was detected in the whole brain (Figure S1B). To
the best of our knowledge, these are the first ISH data showing
that Gb3 synthase mRNA is expressed in the ECs and neurons of
the medulla oblongata and the anterior horn of the spinal cord in
the brains of E32511 model and LPS-injected mice.
Caspase-3 activation in the E32511 model
To investigate apoptosis in the affected mouse brain, we used
immunohistochemistry to detect activated caspase-3. In the
E32511 model, we detected caspase-3 activation in motor neurons
in the anterior horn of the spinal cord (Figure2A), in neurons in
the reticular formation of the medulla oblongata (Figure2B) and in
ECs of the midbrain (Figure2; EC). We also observed caspase-3
activation in the Stx2 (291 ng/kg)-injected mice in the neurons in
the reticular formation of the medulla oblongata (Figure S2A), in
motor neurons in the anterior horn of the spinal cord (Figure S2B),
and in ECs in both areas (Figure S2A inset and S2B inset). After 5
days of E32511 inoculation, clinical symptoms were observed,
such as paraplegia (Figures2C and Video S1), spinal deformity
(Figure2D), and tremor, resulting to mice death within 24 h.
Reconstruction of activated caspase-3 immunostaining clearly
showed the 3-dimensional distribution of the apoptotic motor
neurons in the anterior horn throughout the length of the spinal
cord (Video S2, boxed part in Figure S2C). Overall, we detected
up-regulated Gb3 synthase mRNA in the reticular formation of
the medulla oblongata after oral infection with strain E32511, and
in the anterior horn of the spinal cord after LPS stimulation.
Caspase-3 activation was detected in the same locations as Gb3
synthase mRNA. Importantly, in the purified Stx2 i.p. injected
mouse model, caspase-3 activation was also observed in the
reticular formation of the medulla oblongata and the anterior horn
of the spinal cord. Although we have no evidence of the Stx2
distribution in the mouse model, the ECs and neurons of the
medulla oblongata and the anterior horn of the spinal cord might
be the targets of Stx2c and Stx2. Caspase-3 activation was not
detected in the mice injected i.p. with LPS (500 mg/kg) once a day
for 3 consecutive days (data not shown).
AST reactivity and diminished AQP4 expression in the
E32511 model
We investigated the role of ASTs and the expression of AQP4 in
the E32511 model using immunohistochemistry. GFAP immuno-
reactivity was stronger in the anterior horn of spinal cord of the
E32511 model (Figure3A; GFAP E32511) than in the control
(Figure3A; GFAP cont.) or the LPS-injected mice (Figure3A;
GFAP LPS). Around the reactive ASTs, the neurons in the spinal
cord appeared to be degenerating, with vacuolar changes
(Figure3A; E32511, 10006, arrow). In the reticular formation of
the medulla oblongata, reactive ASTs with strong GFAP
immunoreactivity were observed (Figure3C; GFAP E32511) and
the neurons around the reactive ASTs in the reticular formation of
medulla oblongata also appeared to be degenerating, with
vacuolar changes (Figure3C; E32511, 10006, arrow). In the
control (Figure3C; GFAP cont.) and LPS-injected mice (Figure3C;
GFAP LPS), astrocytic perivascular end-feet were observed
(Figure3C; GFAP cont. and LPS) and ASTs were not reactive,
with normal end-feet (Figure3C; GFAP cont. and LPS).
In the E32511 model, the expression of AQP4 decreased
around the blood vessels in the anterior horn of the spinal cord
(Figure3B; E32511) and the reticular formation of the medulla
oblongata (Figure3D; E32511). On the other hand, a high density
of AQP4 staining was observed in the perivascular areas in the
anterior horn of the spinal cord and the reticular formation of the
medulla oblongata (Figure3B and D; cont. and LPS). Taken
together, our results suggest that the damage to the BBB and
neurons is associated with reactive ASTs. The down-regulation of
AQP4 around the blood vessels may be part of the mechanism of
BBB damage caused by reactive ASTs. Astrogliosis and the down-
regulation of AQP4 around the blood vessels were not observed in
the mice injected i.p. with LPS (500 mg/kg) once a day for 3
consecutive days (data not shown).
Activation of microglia in the i.p. LPS mouse model and
the E32511 model
In this experiment, we investigated whether microglia in the
brain were activated in the E32511 model. Results revealed that
the microglia in the medulla oblongata and the spinal cord of LPS-
injected mice were activated (Figure4A; LPS). Conversely, in the
control (Figure4A; cont.) and E32511-infected mice (Figure4A;
E32511), the microglia were not activated. Furthermore, to
validate our observation, we counted the number of microglia
from 5 non-overlapping fields in both the medulla oblongata and
the spinal cord from each of the control, LPS and E32511 animal
models. Results showed that there was a statistically significant
increase in the number of microglia only in the i.p. injected LPS
mice (p,0.0001). In the control and the E32511 model, microglias
were not activated (Figure4B; cont. and E32511). Taken together,
our results indicate that microgliosis was not associated with the
BBB and neurons damage caused by Stx2c in the E32511 model.
Encephalopathy Caused by Stx2c Producing E. coli
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The effects of AZM on encephalopathy in the E32511
model
Early treatment with a single dose of AZM (200 mg/g) 2 h after
infection with E32511 at 1011 colony-forming unit (CFU) per
mouse resulted in a significant increase in the BW of mice
compared with those of the untreated group and the mice that
were infected and treated 24 h later (p,0.05) (Figure5A). Also at
day 14 after infection, by Student’s t-test, there was a significant
increase in the BW of mice treated 2 h after infection compared
with those treated 6 h after infection (p,0.05) (Figure5B). We
further observed that early treatment with a single dose of AZM
(200 mg/g) 2 h after infection was very effective based on the
survival of the infected mice (Figure5C). To the best of our
knowledge, these are the first data showing that an early treatment
with a single dose of AZM (200 mg/g) is effective in treating the
E32511 model and preventing encephalopathy. Subsequently, we
investigated the effectiveness of AZM in a dose-dependent manner
by applying a single dose of AZM 2 h after infection using a two-
fold serial dilution of AZM (from 1.6 mg/g to 200 mg/g). In this
experiment, mice lost weight after infection with E32511 at 1011
CFU per mouse, in an AZM dose-dependent manner (Figure5D).
By Spearman’s test, there was a statistically significant correlation
between the dose of AZM and the increase in the BW of the
E32511 model mice (p,0.001) (Figure5E). All of the mice treated
with 3.1 mg/g to 200 mg/g of AZM survived compared with those
infected with E32511 and untreated (p,0.001) (Figure5F).
Surprisingly, 80% of the mice treated with the minimum dose of
AZM (1.6 mg/g) 2 h after infection survived (Figure5F) (p,0.05).
Histological examination of the spinal cord and the medulla
oblongata revealed brain lesions in the infected but untreated
Figure 1. ISH of Gb3 synthase in brains of E32511 model and i.p.-injected LPS mice. (A) The brain of E32511-infected mice after
hybridization of Gb3 synthase using Gb3syt anti-sense and sense probes. Scale bars: 1.5 mm. (A.1) Expression of Gb3 synthase was observed with
anti-sense, but not sense probes in E32511-infected mice in the reticular formation of the medulla oblongata. Scale bars: 200 mm. (A.2) Magnification
and expression of Gb3 synthase in endothelial cells (scale bars: 50 mm) and neurons (scale bars: 20 mm) of E32511-infected mouse brain, detected
with anti-sense, but not sense probes. (B) The brain of i.p. LPS-injected mice after hybridization of Gb3 synthase using probe Gb3syt anti-sense and
sense probes. Scale bars: 1.5 mm. (C) Expression of Gb3 synthase was observed in i.p. LPS-injected mice with the anti-sense, but not the sense probe
in the spinal cord. Scale bars: 100 mm. (C.1) Magnification and expression of Gb3 synthase in endothelial cells (scale bars: 30 mm) and neurons (scale
bars: 20 mm) of i.p. LPS-injected mice, detected with the anti-sense, but not the sense probe.
doi:10.1371/journal.pone.0058959.g001
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mice; however, in the control and AZM-treated mice, no brain
lesions were observed (Figures S3 and S4). Moreover, caspase-3
activation was not detected in the brains of mice treated with AZM
(data not shown). Taken together, our results indicate that AZM is
very effective in treating EHEC infection, especially in preventing
encephalopathy in the E32511 model.
The effects of AZM and other antimicrobial agents on
encephalopathy in the E32511 model
We next compared the effectiveness of AZM with that of several
antimicrobial agents recommended by the Japanese Government
(including FOM, KM, and NFLX) in treating the E32511 model.
The new quinolones, OFLX and CPFX, were also included in this
experiment. The concentration of Stx2c in the culture supernatant
was measured in the presence of sub-minimum inhibitory
concentrations (MIC) (0.56 MIC) and the number of E32511
bacteria was counted before and after treatment with the
antimicrobial agents including AZM (Table1). Results revealed
that the number of colonies that grew when treated with each
microbial agent was almost the same. Results also showed that
AZM did not induce the production of Stx2c. However, other
antimicrobial agents induced the production of Stx2c (Figure6A).
FOM, NLFX, KM, OFLX, and CPFX increased Stx2c produc-
tion to 1.5-, 12.5-, 2.25-, 12.5- and 100-fold of control (without the
antimicrobial agents), respectively (Figure6A and Table1). The
concentration of antimicrobials was adjusted to 256MIC and the
mice were treated with a single dose at this concentration 2 h after
infection with the E32511 strain. The results revealed that AZM-
treated mice had a 100% survival rate, which was higher
significantly compared to the untreated group (0% survival rate)
(p,0.01). KM and NFLX-treated mice, on the other hand,
showed an 80% survival rate, which was also significantly higher
Figure 2. Caspase-3 activation in E32511 model mouse brain. Lesions were not detected in the brains of control (uninfected), whereas lesions
were detected in the brains of E32511-infected. Scale bars: 1.5 mm. (A) Caspase-3 activation was detected in the neurons of the mouse spinal cord.
Scale bars: 750 mm and 200 mm (inset). (B) Caspase-3 activation was also detected in neurons of the mouse reticular formation, scale bars: 300 mm
and 200 mm (inset) and endothelial cells of the midbrain. Scale bars: 25 mm. (C) Four week-old female ICR outbred mice after inoculation. The
representative clinical features of flaccid paralysis of the extremities were observed in ICR mice 3 to 5 days after orogastric challenge with E32511 1011
CFU/0.5 mL per mouse (green arrow). (D) Four week-old female ICR mice after inoculation. The representative clinical features of spinal deformity
were observed in ICR mice 3 to 5 days after orogastric challenge with E32511/HSC 1011 CFU/0.5 mL per mouse (green arrow).
doi:10.1371/journal.pone.0058959.g002
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compared to the untreated group (p,0.05) (Figure6B). All the
FOM-treated mice died, and there was no statistically significant
difference between the survival rate of CPFX- or OFLX-treated
mice, and untreated mice (Figure6B). The MIC of CPFX and
OFLX were 0.2 and 0.03 mg/mL, respectively (Table1), and these
new quinolones were shown to have strong bactericidal effects. We
treated the infected mice with high doses of CPFX and OFLX,
3336and 756MIC, respectively. Results showed that there was a
statistically significant difference in the survival rate between mice
treated with these high doses and the untreated mice (Figure S5).
However, the survival rates of CPFX- and OFLX-treated mice
remained at 40% and 30%, respectively. From these results, we
suggest that a single dose of AZM (200 mg/g) given at an early
stage provides more favorable results than other antimicrobial
agents. Additionally, AZM-treated mice survived due in part to a
lower production of Stx2c than in the untreated mice.
Discussion
In this study we report five significant results. 1) Using ISH, we
detected Gb3 synthase mRNA in the neurons and ECs of the
anterior horn of the spinal cord and the reticular formation of the
medulla oblongata of infected mice. Importantly, no Gb3 synthase
mRNA expression was detected in the control mice. In the E32511
model, Gb3 synthase mRNA was up-regulated in the reticular
formation of the medulla oblongata due to bacterial infection-
induced brain Gb3 synthesis and generated toxin receptors. In the
LPS-injected mouse model, Gb3 synthase mRNA was induced in
both the reticular formation of the medulla oblongata and the
spinal cord. 2) In the E32511 model, caspase-3 activation was
detected in neurons and ECs of the anterior horn of the spinal
cord and the reticular formation of the medulla oblongata. 3)
GFAP immunostaining revealed that the ASTs surrounding the
apoptotic neurons of the anterior horn of spinal cord were
activated in the E325211-infected mice, but not in the control and
LPS-injected mice. Also, in the reticular formation of the medulla
oblongata, perivascular cytoplasmic astrogliosis was observed with
a high intensity of GFAP immunostaining. 4) In the E32511
model, perivascular AQP4 could not be detected in the anterior
horn of the spinal cord and the reticular formation of the medulla
oblongata. On the other hand, AQP4 was strongly expressed in
the AST vascular foot processes in control and LPS-injected mice.
The reduced AQP4 expression provided evidence of BBB
impairment. 5) The macrolide antibiotic AZM was strongly
effective in the E32511 model infected with 1011 CFU of E32511.
The receptor for Stxs is synthesized from lactosylceramide by
Gb3 synthase [35]. In a previous report, Gb3 synthase2/2 mice
survived after intravenous injection of Stx1 and Stx2 [36]. Gb3
was found to be expressed in the microvascular ECs of the brain
using immunohistochemistry [36]. Obata et al. also reported that
Figure 3. AST activation and AQP4 expression in E32511 model and i.p. LPS-injected mice. (A) Severe diffuse astrogliosis was observed in
spinal cord of E32511-infected but not in control and LPS-injected mice at low (4006) and high (10006) magnifications. The black arrow shows a
degenerating neuron adjacent to an activated astrocyte. (B) More intense staining of AQP4 was observed surrounding the ECs which comprised the
BBB in the spinal cord in control and LPS-injected mice, but not in E32511-infected mice at low (4006) and high (10006) magnifications. (C) Severe
diffuse astrogliosis was observed in the medulla oblongata of E32511-infected but not in control and LPS-injected mice at low (4006) and high
(10006) magnification. The black arrow shows a degenerating neuron adjacent to an activated astrocyte. (D) More intense staining of AQP4 was
observed surrounding the blood vessels that comprise the BBB in the medulla oblongata in control and LPS-injected mice, but not in E32511-infected
mice at low (4006) and high (10006) magnifications. Scale bars (4006): 2 mm and (10006): 1 mm.
doi:10.1371/journal.pone.0058959.g003
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Gb3 was localized in neurons of mouse brain, and in both neurons
and ECs in human brain [25]. In our study, we found that the pro-
inflammatory response up-regulated Gb3 synthase mRNA in
neurons and ECs of E32511-infected mice, but not in control
mouse brain. The high Gb3 expression in the brain associated
with a pro-inflammatory response may be a risk factor for
neurological impairment in EHEC infection. Importantly, up-
regulated Gb3 was found to be localized in the anterior horn of the
spinal cord and the reticular formation of the medulla oblongata in
our model. Many apoptotic neurons were also observed in the
same area. We previously reported that MRI showed high-
intensity areas in the spinal cord, brain stem, and medulla
oblongata 48 h after i.v. administration of purified Stx2 in rabbits,
and that the cause of death might be circulatory failure caused by
impairment of the cardiovascular centre in the medulla oblongata
[11]. In the E32511 model, E32511-infected mice developed
Figure 4. Microglial activation in i.p. LPS-injected and E32511 model mice. (A) Microglia in the medulla oblongata and the spinal cord were
not activated in the control (uninfected) and E32511-infected mice, but were activated in i.p. LPS-injected mice. Scale bars: 2 mm. (B) The number of
activated microglia significantly increased in the LPS-injected mice but not in the control and E32511-infected mice (LPS vs. control, p,0.0001; LPS vs.
E32511, p,0.0001 and control vs. E32511, p= 1). Microglia were observed and counted manually from 5 non-overlapping fields. Statistical difference
was measured by student’s t test. **p,0.001.
doi:10.1371/journal.pone.0058959.g004
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Figure 5. Effectiveness of a single dose of AZM in the E32511 model. (A) The administration of a single dose of AZM 2 h after infection
significantly increased the BW of E32511-infected mice. (B) Mouse BW for AZM 2 h vs. AZM 6 h, p= 0.015 at day 14 after inoculation. Student’s t test,
*p,0.05; **p,0.001). (C) The administration of a single dose of AZM was significantly effective in the survival mice when given 2 h after infection,
compared with 6 and 24 h after infection, (for AZM 2 h after infection vs. untreated, p= 0.012; AZM 2 h after infection vs. 24 h after infection,
p= 0.013 and AZM 6 h and 24 h after infection vs. untreated, p.0.05. Log rank and x2 test, (*p,0.05) (D) The administration of a single dose of 200–
1.6 mg/g AZM 2 h after infection significantly increased the BW of E32511-infected mice. (E) The correlation between the dose of AZM and the
increase in BW of E32511-infected mice was statistically significant, as shown by the Spearman’s r (rho) = 0.887 and the p value, p,0.0001. Black-filled
circle =AZM 100 mg/g; grey-filled circle = AZM 25 mg/g; empty circle = AZM 6.25 mg/g. (F) 1.6 mg/g AZM 2 h after infection with E32511 (1011 CFU/
mouse) was still effective in treating the E32511-infected mice, with a significant effect on the survival curve (200–6.25 mg/g AZM vs. untreated,
p= 0.002; 3.1 mg/g AZM vs. untreated, p= 0.008 and 1.6 mg/g AZM vs. untreated, p= 0.016. Log rank and x2 test, **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0058959.g005
Figure 6. AZM compared with other antimicrobial agents in the E32511 model. (A) The concentration of Stx2c in NFLX, KM, OFLX, and
CPFX treatment was significantly increased compared with control (no antibiotic) (NFLX vs. control, p=0.023; KM vs. control, p= 0.02; OFLX vs.
control, p= 0.023 and CPPFX vs. control, p= 0.017), while this was not the case for FOM. On the other hand, AZM statistically decreased Stx2c
concentration compared with control (AZM vs. control, p= 0.007). Data were collected from the supernatants of cultures with 2-fold serial dilutions of
each antimicrobial agent and are shown as mean and standard deviations of two independent experiments. Statistical difference was measured by
Student’s t test, *p,0.05. (B) AZM had a statistically significant effect on the mice survival, with 100% survival; NFLX and KM had a statistically
significant effect on the mice survival, with 80% survival (AZM vs. untreated, p= 0.002; AZM vs. FOM, p= 0.003; AZM vs. CPFX, p=0.014; AZM vs. NFLX
and KM, p.0.05). Log Rank and x2 test, *p,0.05.
doi:10.1371/journal.pone.0058959.g006
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paralysis of the upper and lower extremities (Video S1) and
deformity of the spinal cord, which were thought to be due to
apoptosis of the motor neurons in the anterior horn of the cervical
spinal cord (Video S2). Apoptosis of motor neurons in the anterior
horn of the spinal cord that control respiratory function might be
the cause of death in the E32511 model.
In the EHEC O104:H4 outbreak, post-mortem neuropatho-
logical examination of the patients who developed severe
neurological symptoms showed that astrogliosis were most
prominent around the blood vessels, and microgliosis was diffusely
observed in the thalamus and pons in human brain [37]. Golstain
et al. reported that there was a high incidence of injured ASTs
among those that form the BBB with ECs in rats that received
intracerebroventricular administration of Stx2 [38]. The role of
ASTs or microglia in EHEC infection is still unknown. Recently,
AST-derived factors such as TNF-a, nitric oxide, and chemokines
were found to alter the permeability of brain ECs and promote the
adhesion of polymorphonuclear neutrophils and platelets in an in
vitro study [26].
In our E32511 model, we observed GFAP-positive reactive
ASTs around blood vessels in the anterior horn of the spinal cord
and the reticular formation of the medulla oblongata. The
reduction in AQP4 expression around blood vessels suggested
that the integrity of BBB was compromised either by a direct effect
of Stx2c or by reactive ASTs. However, microglias were not
associated with the brain damage caused by E32511. In a previous
report, rats injected i.v. with Stx2 supernatant were shown to have
significantly decreased expression levels of AQP1 and AQP4 in the
brain [27]. In the freeze-injury model of vasogenic brain edema,
AQP4-deficient mice had the worst clinical outcome [39]. It was
also reported that AQP4-null mice had aggravated vasogenic
edema [40]. In our study, we showed that inflammatory stimuli
caused by E32511 infection or i.p. injected LPS increased Gb3
synthase mRNA in ECs and neurons in the anterior horn of the
spinal cord and the reticular formation of the medulla oblongata.
The role of BBB damage is unclear in the Stx toxemia animal
model. Reactive ASTs affected the integrity of the BBB and
polymorphonuclear neutrophil (PMN)-mediated endothelial tox-
icity [41]. Also, ASTs mediated the maintenance of the BBB [42]
and removal of ASTs from co-culture with ECs resulted in
increased permeability [43]. Reactive ASTs can release immune
mediators that may exert neurotoxic effects [44]. Notably, B cell-
activating factor (BAFF), from the TNF superfamily, is strongly
up-regulated in reactive ASTs in the demyelinated lesions of
multiple sclerosis [45]. In the E32511 model, Stx2 was detected in
destroyed nerve fibers whose axons were found to be edematous
and vacuolated [8]. The destroyed nerve fibers might be associated
with BAFF released by the reactive ASTs. It has been reported
that nerve growth factor secreted by reactive ASTs induces motor
neuron apoptosis through a p75NTR-dependent mechanism [46].
In the present study, the activation mechanism of the ASTs still
remains unclear, but the reactive ASTs could amplify the BBB
damage in the E32511 model. We propose three possibilities for
the activation mechanism of ASTs. First, the ASTs could be
directly activated by Stx2c, because Stx2c was detected in mouse
brain parenchyma in ECs and nerve fibers using labeled Stx2c in
an immunoelectron-microscopic study [8]. The reactive ASTs can
then release neurotoxic factors and EC-toxic factors, such as
TNFa, nitric oxide, IL-6, and IL-1b resulting in damage to the
neurons and the BBB. Second, Stx2c absorbed from the mouse
intestine binds to the up-regulated Gb3 of the ECs and causes EC
apoptosis. The leakage of Stx2c through the BBB then causes
neuronal apoptosis. Third, the apoptotic neurons activate the
ASTs, and the reactive ASTs would be unable to support BBB
integrity and would cause the down-regulation of AQP4. Also, the
down-regulation of AQP4 could amplify a signaling loop
associated with vasogenic brain edema.
Recently, Zhang et al. reported that a pediatric dose of AZM
was effective in the piglet model orally infected with Stx2-
producing E. coli, and that rec A mutants treated with the phage-
inducing agent MMC and a sub-inhibitory concentration of
CPFX failed to produce Stx2 [47]. In this study, we investigated
the effectiveness of AZM against the E32511 model infected with
1011 CFU of E32511 and given an i.p. injection of MMC. The
inoculating dose of E32511 in this model was modified from 1010
CFU to 1011 CFU and resulted in 100% death, which was higher
from the previously observed 90% death rate [8]. Based on the
results of treatment with AZM, the administration of a single
200 mg/g dose of AZM 2 h after inoculation of bacteria in the
E32511 model was shown to be significantly effective in improving
the survival of infected mice, compared with those treated either 6
or 24 h after inoculation. Ikeda et al. reported that the early use of
FOM, within the first two days of diarrhea, prevented the
development of HUS [28]. However, FOM therapy on and after
the third day of diarrhea could not prevent HUS. In the E32511
model, MMC might cause a high production of Stx2c from
bacteria 6 h after inoculation with strain E32511. Before the high
production of Stx2c induced by MMC phage induction, AZM
might inhibit the release of the toxin. Apart from these direct
antimicrobial effects, AZM has also been reported to function as
Table 1. Bacterial count at sub-minimum inhibitory concentration (MIC) of AZM and other antimicrobial agents against E32511.
AZM, azithromycin; FOM, fosfomycin; NFLX, norfloxacin; KM, kanamycin; OFLX, orfloxacin; CPFX, ciprofloxacin.
Antimicrobial
agents MIC (mg/mL)
Colony count
(0 h) (CFU/mL)
Colony count at 18 h
after antimicrobial
(0.5xMIC)
Concentration of Stx2c
(folds) added 0.56MIC
Per os dose of
antimicrobial to mice
(256MIC) mg/gram
Survival
rate (%) of
mice
(-) 0 1.06105 1.1860.236109 48623 0 0
AZM 8 3.3760.156108 0 200 100
FOM 1.5 1.3760.236108 40634 39 0
NFLX 0.2 2.6360.156107 6006283 313 80
KM 12.5 1.1760.126109 164651 4.9 80
OFLX 0.2 3.2260.116107 600651 5.0 40
CPFX 0.03 2.5260.236105 480062263 0.75 20
AZM, azithromycin; FOM, fosfomycin; NFLX, norfloxacin; KM, kanamycin; OFLX, orfloxacin; CPFX, ciprofloxacin.
doi:10.1371/journal.pone.0058959.t001
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an immunomodulator to suppress the production of inflammatory
cytokines such as TNF-a, IL-1b, and IL-6 by Stx1 [31].
Intraperitoneal injection of AZM could protect the immature
mice inoculated with 109 CFU/mice orally followed by 3 days
treatment with a high amount of AZM (10 mg/kg) [31]. In our
result, we revealed that oral treatment of AZM could protect the
infected mouse model by inhibiting the production of Shiga toxin
2 using a single lower dose (1.6 mg/kg). AZM showed a 100%
survival rate, while NLFX and KM showed an 80% survival rate,
and FOM showed no significant effect on the survival rate. These
results are in congruence with our in vitro results, in which only
AZM did not induce the production of Stx2c, while the other
antimicrobial agents induced the release of Stx2c. The addition of
antimicrobial agents other than AZM induced higher Stx2c
production than that observed in the positive control without
antimicrobial agents. Antibiotic use during EHEC O157:H7
infections has been reported to be associated with a higher rate of
subsequent HUS and should be avoided [48]. However, in the
biggest outbreak of EHEC O104:H4 in Germany, treatment with
AZM was associated with a lower frequency of long-term STEC
carrier status [49].
To investigate encephalopathy caused by EHEC infection and
i.p.-injected LPS, we first succeeded in detecting Gb3 synthase
mRNA by ISH. High Gb3 synthase mRNA expression was found
in the ECs and neurons in the anterior horn of the spinal cord and
the reticular formation of the medulla oblongata. To understand
the mechanism of BBB damage in our mouse model inoculated
with 1011 CFU of E32511, we focused on the pro-inflammatory
response caused by Stx2c-producing EHEC. The pro-inflamma-
tory response induced up-regulation of Gb3 synthase mRNA in
ECs and neurons, activation of ASTs, and a decrease in AQP4. In
conclusion, apoptosis of the neurons in the spinal cord and in the
medulla oblongata, together with respiratory and autonomic
dysfunction, may be the cause of death in our mouse model.
Supporting Information
Figure S1 (A) Sagittal sections of the whole brain of control mice
hybridized with anti-sense and sense Gb3 synthase probes. (B)
Sagittal sections of the whole brain of E32511-infected and LPS
administered intraperitoneally mice hybridized with anti-sense b-
actin probe. Scale bars: 3 mm.
(TIF)
Figure S2 Caspase-3 activation in mouse brain injected
with Stx2. Whole brain of i.p. Stx2-injected mice. Scale bars:
3 mm. (A) Caspase-3 activation was detected in the neurons of the
reticular formation of the medulla oblongata. Scale bars: 200 mm.
(B) Caspase-3 activation was detected in the neurons of the
anterior horn of the spinal cord. (C) The orientations of 3D images
of the mouse spinal cord (Video S2) is shown in the boxed part of
C.
(TIF)
Figure S3 Structural features of histological changes in
the spinal cord of the E32511 model. Sections of the spinal
cord from control (uninfected) mice (A, D, G), AZM-untreated
mice (B, E, H) and AZM-treated mice (C, F, I) stained with H&E
are shown. A–C with original 1006 magnification; D–F with
4006 magnification and G–I with 10006 magnification. Intact
motor neurons were observed in control (uninfected) mice: A, D,
G and AZM-treated mice: C, F, I. Degenerating motor neurons
with vacuolar changes (arrow in H) were observed in AZM-
untreated mice: B, E, H. Scale bars: A: 10 mm; D: 2 mm; G:
1 mm.
(TIF)
Figure S4 Structural features of histological changes in
the medulla oblongata of the E32511 model. Sections of
brain stems (medulla oblongata) from control (uninfected) mice (A,
D, G), AZM-untreated mice (B, E, H) and AZM-treated mice (C,
F, I) stained with H&E are shown. A–C with original 1006
magnification; D–F with 4006 magnification; and G–I with
10006 magnification. Intact neurons were observed in control
(uninfected) mice: A, D, G and AZM-treated mice: C, F, I.
Degenerating neurons with vacuolar changes (arrows in E and H)
were observed in the reticular formation in AZM-untreated mice:
B, E, H. Scale bars: A: 10 mm; D: 2 mm; G: 1 mm.
(TIF)
Figure S5 Clinical dose of CPFX and OFLX in the
E32511 model. 10 mg/g CPFX 10 and 15 mg/g OFLX 15 had a
statistically significant effect on the mice survival; however, CPFX
and OFLX treatments were not very effective, with 40% and 30%
survival, respectively (CPFX vs. untreated, p,0.0001; OFLX vs.
untreated, p=0.013. Log Rank and x2 test, *p,0.05, **p,0.001.
(TIF)
Table S1 Sequence of probes used in in situ hybridiza-
tion.
(PDF)
Video S1 Video of the mouse showing symptoms after
infection with E32511 161011 CFU/0.5 mL. The symptoms
developed from 3 to 5 days after E32511 infection. The symptoms
of tremor, paralysis of hind extremities, and spinal deformity were
observed in infected, but not uninfected mice.
(MP4)
Video S2 The orientation of 3D images of the mouse
spinal cord is shown in the boxed part of A in Figure
S2C. Apoptotic motor neurons are indicated in the anterior horn
of the spinal cord of mice infected with EHEC O 157 :H- Strain
E32511 161011 CFU.
(MP4)
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